Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or West Virginia for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to West Virginia only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. West Virginia (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Scott Jamerson (NPI 1710180534)

Field	Value
Entity Type	Individual
Organization	Scott Jamerson
Address	331 Laidley St.
City	Charleston
State	WV
ZIP	25339
Taxonomy	Retina Specialist (Ophthalmology) Physician
NPI Enumerated	June 8, 2007

Payer Source	Total Paid
Medicare	$2.4M
Medicaid	$0

Key Findings

SCOTT JAMERSON is a retina specialist (Ophthalmology) based in CHARLESTON, WV with an NPI enumerated 2007-06-08 (~19 years ago). Lifetime Medicare revenue on file is $2.4M and there is no Medicaid billing on file, indicating the provider operates effectively as a Medicare-focused practice.

Revenue is highly concentrated in a small set of intravitreal and vitreous-procedure codes: the precomputed top three Medicare codes account for 84.3% of this provider's Medicare revenue. The single largest contributor is J0178 (aflibercept) at $1.5M (61.2% of Medicare revenue), followed by J2777 (faricimab) at $431.8K (17.9%) and 67028 (vitreous injection) at $125K (5.2%).

The code mix and dollar distribution point to a procedure-heavy retina practice centered on intravitreal biologic therapy and isolated vitreous injections. High revenue from J0178 and J2777 combined with substantial billing for 67028 implies the clinic’s operational model prioritizes administration of anti-VEGF agents and same-day or separate intravitreal procedures rather than primary-volume primary-care ophthalmology visits.

Diagnostic imaging activity is an outlier relative to peers: 92134 shows 2.3K claims for $64.6K (2.7% of Medicare revenue) and is labeled an "extreme outlier, far above typical national volume" at the 97th percentile. This suggests unusually high retinal imaging throughput or frequent monitoring visits, consistent with active management of neovascular retinal disease in a largely Medicare population.

Competitive standing on the main therapy codes is mixed: J0178 ranks #455 of 3204 providers nationally (86th percentile), indicating an above-average but not dominant national position for aflibercept administration, while J2777 ranks #693 of 2039 (66th percentile), reflecting more typical peer volume for faricimab. These ranks imply the provider is a solid regional/top-quartile participant for aflibercept but a more modest player for newer biologics.

The practice shows little to no exposure to Medicaid revenue ("none below"), making it effectively single-payer with Medicare as the dominant source. This payer concentration implies patient demographics skew toward Medicare beneficiaries and may limit revenue diversification tied to state Medicaid contracts or low-income populations.

Procedure breadth includes notable laser and office-visit activity: 67210 (retinal laser) generated $35.3K and ranks #63 of 420 (85th percentile), while 99213 office visits produced $30.9K and rank #29609 of 457151 (93rd percentile). Together, these codes indicate the provider delivers both procedural retina care and routine established-patient management in addition to injection services.

There is a clear therapeutic preference pattern in the drug mix: ranibizumab (J2778) shows relatively low national standing (rank #1086 of 1208, 10th percentile), while unclassified drug billing (J3490) and bevacizumab (J9035) are middling in rank. This suggests operational reliance on aflibercept and faricimab over ranibizumab and limited use of bevacizumab or miscellaneous drug billing in Medicare.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

17 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J0178	Injection, aflibercept, 1 mg	2,170	$680	$1.5M
J2777	Injection, faricimab‑svoa, 0.1 mg	15,420	$30	$431.8K
67028	The provider injects a medication into the vitreous chamber of the eye as an isolated procedure or a separate procedure unrelated to any other procedure being performed on the eye.	1,520	$80	$125K
J3490	Unclassified drugs	60	$2,090	$115K
92134	The provider performs computerized diagnostic imaging of the retina in the posterior segment (back part) of the eye, interprets the data, and provides a report. The service may be on one or both eyes.	2,310	$30	$64.6K
92014	An ophthalmologist sees an established patient for a comprehensive level eye examination. Generally, a patient is considered to be "established" if the same physician, or any physician in the group…	590	$80	$49.8K
67210	The provider destroys a lesion of the retina using a laser beam that heats up the tissue.	90	$420	$35.3K
J2778	Injection, ranibizumab, 0.1 mg	220	$160	$34.1K
99213	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the…	480	$70	$30.9K
92235	The provider uses a special dye, fluorescein that causes the blood vessels in the one or both eyes to stand out in photographic images taken with the use of multiframe timing, or serial images, taken…	190	$90	$16.9K

Showing 1–10 of 17

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 17 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. West Virginia Distribution

Scott Jamerson — 3 of 17 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — West Virginia

Full comparison — all codes billed, vs. state median

17 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J0178	4	10	2,090	$690	$1.7M
J2777	2	10	8,490	$30	$456.6K
67028	3	10	770	$80	$94.4K
J3490	1	10	40	$1,970	$77K
J2778	4	10	370	$180	$74.3K
67210	1	10	60	$380	$21.3K
92014	18	180	120	$70	$16.3K
J9035	4	10	90	$50	$9.3K
92235	2	10	70	$90	$9K
99213	162	2,860	80	$50	$7.5K

Showing 1–10 of 17

Related Providers

Other providers that share a Tax Identification Number (TIN) with Scott Jamerson, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Retina Consultants, PLLC	WV	Retina Specialist (Ophthalmology) Physician	$0	$13.6M
Abraham Mitias	WV	Retina Specialist (Ophthalmology) Physician	$3.7M	$0
Daniel Richardson	WV	Retina Specialist (Ophthalmology) Physician	$2.5M	$0
Richard Hatfield	WV	Retina Specialist (Ophthalmology) Physician	$2.2M	$0
David Hunt	WV	Retina Specialist (Ophthalmology) Physician	$2.1M	$0
Robert Dundervill	WV	Retina Specialist (Ophthalmology) Physician	$1.3M	$0
Chaitanya Indukuri	TX	Ophthalmology Physician	$1.1M	$0

Scott Jamerson — Billing Profile & Reimbursement Data

Sign up for Scott Jamerson — Billing Profile & Reimbursement Data policy alerts

Scott Jamerson — Billing Profile & Reimbursement Data

Sign up for Scott Jamerson — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Frequently Asked Questions

References